Thermo Fisher Scientific’s Revolutionary Glacios 3 Cryo-TEM Enhances Accessibility

Thermo Fisher Scientific has revolutionized structural biology research with the launch of the Glacios 3 Cryo-TEM, enabling broader access to advanced cryogenic electron microscopy (cryo-EM) by minimizing the need for extensive lab renovations. This innovative product integrates cutting-edge features like AI-powered software and the READY System, facilitating clearer insights into drug design and biological structures.

Thermo Fisher Scientific, a leader in the scientific industry with over $40 billion in annual revenue, has taken a significant step in making cryo-EM accessible to more labs by unveiling the Glacios 3 Cryo-TEM. Cryo-EM, known for its critical role in developing vaccines and therapeutic treatments, is now easier to implement thanks to the instrument’s new capabilities. The integrated READY System reduces vibrations and simplifies installation requirements, eliminating costly renovations. With enhanced AI-driven workflows, researchers can expect increased data throughput and quality, benefitting from techniques like single particle analysis and cryo-electron tomography.

The introduction of the Glacios 3 Cryo-TEM marks a pivotal moment for structural biology labs seeking advanced research tools without substantial infrastructure investment. By broadening access and enhancing research capabilities, Thermo Fisher is empowering scientists to tackle complex questions and accelerate the development of groundbreaking therapies. This launch underscores Thermo Fisher’s commitment to making scientific research more efficient and widely available, promising a future of enhanced insights and therapeutic advancements.